http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-34744-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5edd48190cba3fa70dd3975efd9831
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C315-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C201-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
filingDate 1970-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-34744-L
titleOfInvention Biphenyl crotonic acids.
abstract 1322370 Analgesic &c medicines DR KARL THOMAE GmbH 16 Nov 1970 [17 Nov 1969 29 Sept 1970 (4)] 54474/70 Heading A5B [Also in Division C2] Pharmaceutical compositions having antiphlogistic, analgesic and antitussive activity and an effect on the prolongation of bleeding time comprise, as active ingredient, a 4-[biphenylyl- (4)]-4-hydroxycrotonic acid of the general formula: wherein each of R 1 , R 2 and R 3 is a hydrogen atom or one or two of R 1 , R 2 and R 3 is/are selected from halogen atoms and C 1-4 alkyl, C 1-4 hydroxyalkyl, nitro, amino, acetylamino, cyano, carbethoxy, hydroxy, methoxy, methylthio, methylsulphinyl, methylsulphonyl and optionally methyl-substituted carbamoyl groups and the other(s) is/are a hydrogen atom or hydrogen atoms, or a physiologically compatible base addition salt thereof, in association with a pharmaceutical carrier or excipient and, optionally, a further physiologically active ingredient, e.g. p-ethoxy-acetanilide. They may be administered orally, rectally or parenterally as granules, tablets, coated tablets, capsules, syrups, emulsions, suspensions, drops, ampoules or suppositories. (From GB1322370 A) [FR2073368A1]
priorityDate 1969-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4754

Total number of triples: 62.